Amy Hobeika
- Immunology top 0.5%
- Molecular Biology top 5%
- Oncology top 1%
- Cancer Research top 2%
- Genetics top 10%
- Co-authors
- H. Kim LyerlyMichael A. MorseTimothy M. ClayTakuya OsadaHoward M. JohnsonDonna NiedzwieckiAlain DelcayreJean‐Bernard Le Pecq
- Topics
- Immunotherapy and Immune Responses (55 papers)Cancer Immunotherapy and Biomarkers (28 papers)Immune Cell Function and Interaction (22 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Journals
- Proceedings of the National Academy of SciencesJournal of Clinical InvestigationNature Communications
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Amy Hobeika
86 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Immunology 2.5k
- Molecular Biology 2.0k
- Oncology 1.7k
- Cancer Research 724
- Genetics 318
Countries citing papers authored by Amy Hobeika
This map shows the geographic impact of Amy Hobeika's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Hobeika with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Hobeika more than expected).
Fields of papers citing papers by Amy Hobeika
This network shows the impact of papers produced by Amy Hobeika. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Hobeika. The network helps show where Amy Hobeika may publish in the future.
Co-authorship network of co-authors of Amy Hobeika
This figure shows the co-authorship network connecting the top 25 collaborators of Amy Hobeika. A scholar is included among the top collaborators of Amy Hobeika based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Hobeika. Amy Hobeika is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 16 | |
| 3 | 5 | |
| 4 | 8 | |
| 5 | 54 | |
| 6 | 52 | |
| 7 | 38 | |
| 8 | 15 | |
| 9 | 64 | |
| 10 | 14 | |
| 11 | 8 | |
| 12 | 78 | |
| 13 | 112 | |
| 14 | 21 | |
| 15 | 19 | |
| 16 | 61 | |
| 17 | 7 | |
| 18 | 55 | |
| 19 | Down-regulation of neu/HER-2 by interferon-gamma in prostate cancer cells. | 50 |
| 20 | 57 |
About Amy Hobeika
Amy Hobeika is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging, having authored 90 papers that have together received 4.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (55 papers), Cancer Immunotherapy and Biomarkers (28 papers) and Immune Cell Function and Interaction (22 papers). The work is most often cited by research in Immunology (2.5k citations), Oncology (1.7k citations) and Cancer Research (724 citations). Amy Hobeika has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include H. Kim Lyerly, Michael A. Morse, Timothy M. Clay, Takuya Osada, Howard M. Johnson, Donna Niedzwiecki, Alain Delcayre, Jean‐Bernard Le Pecq, Prem S. Subramaniam and Paul J. Mosca. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.